HasanSyedJafriMDFAAP

Infectious Disease • San Jose, CA

Healthcare Associated Infections, Transplant/Immunocompromised States, Clinical Pharmacology

Chief Medical Officer, Head of Clinical Development

Join to view full profile

Dr. Jafri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jafri's full profile

Already have an account?

Office
5941 Optical Ct
San Jose, CA 95138

Education & Training

University of Texas Southwestern Medical Center1996 - 1999
University of Texas Medical Branch HospitalsResidency, Pediatrics, 1993 - 1996
Centers for Disease Control and PreventionPost-Doctoral Fellowship, 1992 - 1993
Allama Iqbal Medical CollegeClass of 1990

Certifications & Licensure

TX State Medical License 1999 - 2026
National Board of Physicians and Surgeons Pediatrics

Clinical Trials

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States Start of enrollment: 2004 Nov 15
Completed
Phase 3
Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) Start of enrollment: 2011 Oct 20
Terminated
Phase 1
MEDI-557 Adult Dosing Start of enrollment: 2012 Mar 01
Completed
Phase 1
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects Start of enrollment: 2013 Jan 01
Completed
Phase 1
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults Start of enrollment: 2014 Sep 04
Completed
Phase 1
Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects Start of enrollment: 2016 Mar 25
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

25 citations
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mecha...
Jean Chastre, Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer
Critical Care. 2022-11-15
3 citations
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Vent...
Alexey Ruzin, Olivier Barraud, Li Yu, Bruno François, Miguel Sánchez-Garcia
Journal of Clinical Microbiology. 2022-07-20
37 citations
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, plac...
Bruno François, Hasan S Jafri, Jean Chastre, Miguel Sánchez-García, Philippe Eggimann
The Lancet. Infectious Diseases. 2021-04-21

Press Mentions

Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis PatientsMarch 13th, 2023
New Approaches to Treating Infections in Cystic Fibrosis Patients - AR 501 Phase 2 Trial UpdateJanuary 17th, 2023
Phase 2a Trial of AR-501 for Lung Infections in CF Now Fully EnrolledDecember 1st, 2022
Join now to see all

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
American Thoracic Society - ATS
Member
American Society for Microbiology
Member
Pediatric Infectious Diseases Society
Member
European Society of Clinical Microbiology and Infectious Diseases
Member
European Society for Paediatric Infectious Diseases
Member

Other Languages

Hindi, Urdu, Punjabi

External Links

LinkedInhttp://linkedin.com/in/hasan-jafri-b0b6836